CANY
EVH icon

Caxton Associates (New York)’s Evolent Health EVH Stock Holding History

Caxton Associates (New York)’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-22,283
Closed -$691K – 589
2021
Q3 		$691K Buy
22,283
+8,767
+65% +$210K 0.08% 149
2021
Q2 		$285K Buy
+13,516
New +$271K 0.03% 325

Other funds holding EVH

EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Caxton Associates (New York)'s EVH Position: Q4 2021 in Review

Caxton Associates (New York) sold out of Evolent Health (EVH) in Q4 2021, closing a stake of 22,283 shares — an estimated $691K sold.

Caxton Associates (New York) first reported a position in EVH in Q2 2021 and held it in 2 quarters. The position peaked at $691K in Q3 2021. 207 funds tracked by Wall St. Rank hold EVH as of Q4 2021.

  • Caxton Associates (New York) reported no remaining Evolent Health position as of Q4 2021 after selling out during the quarter.
  • Caxton Associates (New York) sold 22,283 Evolent Health shares in Q4 2021, an estimated $691K.
  • Caxton Associates (New York) first reported a position in Evolent Health in Q2 2021 and held it in 2 quarters.
  • Caxton Associates (New York)'s Evolent Health position peaked at $691K in Q3 2021.
  • 207 funds tracked by Wall St. Rank held Evolent Health as of Q4 2021.

Based on Caxton Associates (New York)'s 13F filing for Q4 2021, filed 14 Feb 2022.